409 related articles for article (PubMed ID: 21613474)
1. Induction of intracellular tau aggregation is promoted by α-synuclein seeds and provides novel insights into the hyperphosphorylation of tau.
Waxman EA; Giasson BI
J Neurosci; 2011 May; 31(21):7604-18. PubMed ID: 21613474
[TBL] [Abstract][Full Text] [Related]
2. The neurotoxin, MPP+, induces hyperphosphorylation of Tau, in the presence of alpha-Synuclein, in SH-SY5Y neuroblastoma cells.
Duka T; Sidhu A
Neurotox Res; 2006 Aug; 10(1):1-10. PubMed ID: 17000465
[TBL] [Abstract][Full Text] [Related]
3. α-Synuclein Fibrils Exhibit Gain of Toxic Function, Promoting Tau Aggregation and Inhibiting Microtubule Assembly.
Oikawa T; Nonaka T; Terada M; Tamaoka A; Hisanaga S; Hasegawa M
J Biol Chem; 2016 Jul; 291(29):15046-56. PubMed ID: 27226637
[TBL] [Abstract][Full Text] [Related]
4. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells.
Luk KC; Song C; O'Brien P; Stieber A; Branch JR; Brunden KR; Trojanowski JQ; Lee VM
Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20051-6. PubMed ID: 19892735
[TBL] [Abstract][Full Text] [Related]
5. Discovery of small molecule benzothiazole and indole derivatives tackling tau 2N4R and α-synuclein fibrils.
Elbatrawy AA; Ademoye TA; Alnakhala H; Tripathi A; Zami A; Ostafe R; Dettmer U; Fortin JS
Bioorg Med Chem; 2024 Feb; 100():117613. PubMed ID: 38330847
[TBL] [Abstract][Full Text] [Related]
6. Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases.
Nonaka T; Watanabe ST; Iwatsubo T; Hasegawa M
J Biol Chem; 2010 Nov; 285(45):34885-98. PubMed ID: 20805224
[TBL] [Abstract][Full Text] [Related]
7. Alpha-synuclein induces hyperphosphorylation of Tau in the MPTP model of parkinsonism.
Duka T; Rusnak M; Drolet RE; Duka V; Wersinger C; Goudreau JL; Sidhu A
FASEB J; 2006 Nov; 20(13):2302-12. PubMed ID: 17077307
[TBL] [Abstract][Full Text] [Related]
8. α-Synuclein modulates tau spreading in mouse brains.
Bassil F; Meymand ES; Brown HJ; Xu H; Cox TO; Pattabhiraman S; Maghames CM; Wu Q; Zhang B; Trojanowski JQ; Lee VM
J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33091110
[TBL] [Abstract][Full Text] [Related]
9. E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment.
Emmer KL; Waxman EA; Covy JP; Giasson BI
J Biol Chem; 2011 Oct; 286(40):35104-18. PubMed ID: 21846727
[TBL] [Abstract][Full Text] [Related]
10. A novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that inhibit amyloid formation.
Waxman EA; Giasson BI
J Neurochem; 2010 Apr; 113(2):374-88. PubMed ID: 20132485
[TBL] [Abstract][Full Text] [Related]
11. Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease.
Wills J; Credle J; Haggerty T; Lee JH; Oaks AW; Sidhu A
PLoS One; 2011 Mar; 6(3):e17953. PubMed ID: 21445308
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of the interplay between α-synuclein and Tau in regulating pathological amyloid aggregation.
Lu J; Zhang S; Ma X; Jia C; Liu Z; Huang C; Liu C; Li D
J Biol Chem; 2020 May; 295(21):7470-7480. PubMed ID: 32291284
[TBL] [Abstract][Full Text] [Related]
13. GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein.
Credle JJ; George JL; Wills J; Duka V; Shah K; Lee YC; Rodriguez O; Simkins T; Winter M; Moechars D; Steckler T; Goudreau J; Finkelstein DI; Sidhu A
Cell Death Differ; 2015 May; 22(5):838-51. PubMed ID: 25394490
[TBL] [Abstract][Full Text] [Related]
14. Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease.
Haggerty T; Credle J; Rodriguez O; Wills J; Oaks AW; Masliah E; Sidhu A
Eur J Neurosci; 2011 May; 33(9):1598-610. PubMed ID: 21453448
[TBL] [Abstract][Full Text] [Related]
15. Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death.
Mahul-Mellier AL; Vercruysse F; Maco B; Ait-Bouziad N; De Roo M; Muller D; Lashuel HA
Cell Death Differ; 2015 Dec; 22(12):2107-22. PubMed ID: 26138444
[TBL] [Abstract][Full Text] [Related]
16. Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models.
Duka T; Duka V; Joyce JN; Sidhu A
FASEB J; 2009 Sep; 23(9):2820-30. PubMed ID: 19369384
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of N- and O-Linked Indole Triazines for a Dual Effect on α-Synuclein and Tau Aggregation.
Ramirez E; Ganegamage SK; Min S; Patel H; Ogunware A; Plascencia-Villa G; Alnakhala H; Shimanaka K; Tripathi A; Wang KW; Zhu X; Rochet JC; Kuo MH; Counts SE; Perry G; Dettmer U; Lasagna-Reeves CA; Fortin JS
ACS Chem Neurosci; 2023 Nov; 14(21):3913-3927. PubMed ID: 37818657
[TBL] [Abstract][Full Text] [Related]
18. Distinct α-synuclein strains differentially promote tau inclusions in neurons.
Guo JL; Covell DJ; Daniels JP; Iba M; Stieber A; Zhang B; Riddle DM; Kwong LK; Xu Y; Trojanowski JQ; Lee VM
Cell; 2013 Jul; 154(1):103-17. PubMed ID: 23827677
[TBL] [Abstract][Full Text] [Related]
19. Pα-syn* mitotoxicity is linked to MAPK activation and involves tau phosphorylation and aggregation at the mitochondria.
Grassi D; Diaz-Perez N; Volpicelli-Daley LA; Lasmézas CI
Neurobiol Dis; 2019 Apr; 124():248-262. PubMed ID: 30472299
[TBL] [Abstract][Full Text] [Related]
20. Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein.
Sengupta U; Puangmalai N; Bhatt N; Garcia S; Zhao Y; Kayed R
Mol Neurobiol; 2020 Jun; 57(6):2741-2765. PubMed ID: 32350746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
